Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures

S. N. Hayes, David Holmes, R. A. Nishimura

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Percutaneous aortic balloon valvuloplasty (PABV) is useful in palliating symptoms of severe aortic stenosis in patients who are not candidates for aortic valve replacement. In 15 patients who had severe aortic stenosis and a contraindication to aortic valve replacement, PABV was performed before a noncardiac procedure, in an attempt to improve their hemodynamics and reduce the risks associated with the operation or preoperative diagnostic test. The mean aortic gradient was reduced from 58.1 ± 6.0 mm Hg to 32.2 ± 4.0 mm Hg (P < 0.0002), and the aortic valve area was increased from 0.49 ± 0.04 cm 2 to 0.85 ± 0.10 cm 2 (P < 0.0002). Complications associated with PABV included left ventricular perforation in three patients (which resulted in death in one of them), transient congestive heart failure in one, and development of femoral pseudoaneurysms in one. After PABV, nine patients underwent the planned surgical procedure under general anesthesia without complications. Five patients underwent surgical diagnostic procedures after PABV that resulted in a change in treatment strategy. Three of these patients required no further treatment, and two required resection of the colon for bleeding, which was preceded by aortic valve replacement. This study demonstrates that PABV may be useful in reducing the risks of noncardiac procedures in selected patients with severe aortic stenosis who are otherwise not candidates for aortic valve replacement.

Original languageEnglish (US)
Pages (from-to)753-757
Number of pages5
JournalMayo Clinic Proceedings
Volume64
Issue number7
StatePublished - 1989

Fingerprint

Balloon Valvuloplasty
Aortic Valve
Aortic Valve Stenosis
False Aneurysm
Thigh
Routine Diagnostic Tests
General Anesthesia
Colon
Heart Failure
Hemodynamics
Hemorrhage
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures. / Hayes, S. N.; Holmes, David; Nishimura, R. A.

In: Mayo Clinic Proceedings, Vol. 64, No. 7, 1989, p. 753-757.

Research output: Contribution to journalArticle

@article{7fc80ba029764c7aa0875112268a015f,
title = "Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures",
abstract = "Percutaneous aortic balloon valvuloplasty (PABV) is useful in palliating symptoms of severe aortic stenosis in patients who are not candidates for aortic valve replacement. In 15 patients who had severe aortic stenosis and a contraindication to aortic valve replacement, PABV was performed before a noncardiac procedure, in an attempt to improve their hemodynamics and reduce the risks associated with the operation or preoperative diagnostic test. The mean aortic gradient was reduced from 58.1 ± 6.0 mm Hg to 32.2 ± 4.0 mm Hg (P < 0.0002), and the aortic valve area was increased from 0.49 ± 0.04 cm 2 to 0.85 ± 0.10 cm 2 (P < 0.0002). Complications associated with PABV included left ventricular perforation in three patients (which resulted in death in one of them), transient congestive heart failure in one, and development of femoral pseudoaneurysms in one. After PABV, nine patients underwent the planned surgical procedure under general anesthesia without complications. Five patients underwent surgical diagnostic procedures after PABV that resulted in a change in treatment strategy. Three of these patients required no further treatment, and two required resection of the colon for bleeding, which was preceded by aortic valve replacement. This study demonstrates that PABV may be useful in reducing the risks of noncardiac procedures in selected patients with severe aortic stenosis who are otherwise not candidates for aortic valve replacement.",
author = "Hayes, {S. N.} and David Holmes and Nishimura, {R. A.}",
year = "1989",
language = "English (US)",
volume = "64",
pages = "753--757",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "7",

}

TY - JOUR

T1 - Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures

AU - Hayes, S. N.

AU - Holmes, David

AU - Nishimura, R. A.

PY - 1989

Y1 - 1989

N2 - Percutaneous aortic balloon valvuloplasty (PABV) is useful in palliating symptoms of severe aortic stenosis in patients who are not candidates for aortic valve replacement. In 15 patients who had severe aortic stenosis and a contraindication to aortic valve replacement, PABV was performed before a noncardiac procedure, in an attempt to improve their hemodynamics and reduce the risks associated with the operation or preoperative diagnostic test. The mean aortic gradient was reduced from 58.1 ± 6.0 mm Hg to 32.2 ± 4.0 mm Hg (P < 0.0002), and the aortic valve area was increased from 0.49 ± 0.04 cm 2 to 0.85 ± 0.10 cm 2 (P < 0.0002). Complications associated with PABV included left ventricular perforation in three patients (which resulted in death in one of them), transient congestive heart failure in one, and development of femoral pseudoaneurysms in one. After PABV, nine patients underwent the planned surgical procedure under general anesthesia without complications. Five patients underwent surgical diagnostic procedures after PABV that resulted in a change in treatment strategy. Three of these patients required no further treatment, and two required resection of the colon for bleeding, which was preceded by aortic valve replacement. This study demonstrates that PABV may be useful in reducing the risks of noncardiac procedures in selected patients with severe aortic stenosis who are otherwise not candidates for aortic valve replacement.

AB - Percutaneous aortic balloon valvuloplasty (PABV) is useful in palliating symptoms of severe aortic stenosis in patients who are not candidates for aortic valve replacement. In 15 patients who had severe aortic stenosis and a contraindication to aortic valve replacement, PABV was performed before a noncardiac procedure, in an attempt to improve their hemodynamics and reduce the risks associated with the operation or preoperative diagnostic test. The mean aortic gradient was reduced from 58.1 ± 6.0 mm Hg to 32.2 ± 4.0 mm Hg (P < 0.0002), and the aortic valve area was increased from 0.49 ± 0.04 cm 2 to 0.85 ± 0.10 cm 2 (P < 0.0002). Complications associated with PABV included left ventricular perforation in three patients (which resulted in death in one of them), transient congestive heart failure in one, and development of femoral pseudoaneurysms in one. After PABV, nine patients underwent the planned surgical procedure under general anesthesia without complications. Five patients underwent surgical diagnostic procedures after PABV that resulted in a change in treatment strategy. Three of these patients required no further treatment, and two required resection of the colon for bleeding, which was preceded by aortic valve replacement. This study demonstrates that PABV may be useful in reducing the risks of noncardiac procedures in selected patients with severe aortic stenosis who are otherwise not candidates for aortic valve replacement.

UR - http://www.scopus.com/inward/record.url?scp=0024440014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024440014&partnerID=8YFLogxK

M3 - Article

C2 - 2475727

AN - SCOPUS:0024440014

VL - 64

SP - 753

EP - 757

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 7

ER -